Four EUDAMED modules become mandatory across the device market
The transition moves actor, device, certificate, and market-surveillance records from voluntary use into required EU operating workflows, increasing the cost of disconnected regulatory data.
Editorial figure by RegQuality Review. Source context: European Commission Directorate-General for Health and Food Safety.
A regulatory-data operating change
Mandatory use increases the consequence of mismatches among product lifecycle, quality, regulatory, labeling, certificate, and economic-operator records. The practical work is not limited to transferring data into a portal. Organizations need ownership for creating, reviewing, maintaining, reconciling, and retiring the information over the device lifecycle.
Different modules also involve different actors. Manufacturers, authorised representatives, importers, notified bodies, and authorities do not share identical duties or system access. Buyers should avoid a single EUDAMED-ready checkbox that hides those workflow and responsibility boundaries.
The systems question starts upstream
Device identifiers, product attributes, certificates, market status, and quality events often originate in different systems. A regulatory platform can coordinate these records, but the organization still needs authoritative sources, data stewards, controlled handoffs, and exception resolution.
A credible evaluation should test a real lifecycle change. Teams can ask how a certificate update or device change propagates, who reviews downstream impact, which EUDAMED record is affected, how rejection is handled, and what evidence remains after the transaction.
How the provider market should be compared
Medical-device eQMS, product-lifecycle, RIM, and specialist submission tools may each own a portion of the workflow. Their overlap does not make them equivalent. Comparisons should identify record ownership, supported module interactions, integration method, human review points, and the source of each claim.
RegQuality Review will treat EUDAMED coverage as a set of evidence-backed functions. A vendor statement may establish positioning; observed workflow, current documentation, and verified customer use provide stronger support.
Enterprise buyer test
Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.
A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.
What we will watch next
RegQuality Review will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.